lgg101

Leonard Gomella, MD

Contact Dr. Gomella

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Most Recent Peer-reviewed Publications

  1. Editorial comment
  2. Multidisciplinary clinical treatment of head and neck cancer
  3. VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen
  4. Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study
  5. The cost of prostate Ca care: What counts for AS?
  6. Prostate cancer CRPC stage M0 and M1: Do we need stage M0.5?
  7. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study
  8. Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017
  9. Hematologic Toxicity From Radium-223 Therapy for Bone Metastases in Castration-Resistant Prostate Cancer: Risk Factors and Practical Considerations
  10. New urologic oncology drugs and the new toxicities
  11. The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin
  12. Intravesical rAd–IFNa/Syn3 for patients with high-grade, bacillus calmette-guerin–refractory or relapsed non–muscle-invasive bladder cancer: A phase II randomized study
  13. VAPC-1 Targeted64Cu-TP3805 kit preparation and its evaluation
  14. Prostate MRI: Value in surgical planning?
  15. Nonpalpable Intratesticular Mass in a Young Man With a History of Contralateral Retractile Testis
  16. Nonpalpable intratesticular mass in a young man with a history of contralateral retractile testis
  17. The urology guide to coffee and tea
  18. Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study
  19. Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts
  20. The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II)